APGE - Apogee Therapeutics, Inc.

QQQ $ 629.78 $ -3.11 (-0.49 %)

DIA $ 472.70 $ -2.66 (-0.56 %)

SPY $ 681.88 $ -2.29 (-0.33 %)

TLT $ 89.68 $ 0.07 (0.08 %)

GLD $ 366.72 $ 0.05 (0.01 %)

Previous Close

$ 54.35

Open

$ 56.98

Bid

$ 50.10 x 25

Ask

$ 62.00 x 1

Day's Range

$ 53.53 - $ 58.36

52 Week Range

$ 26.20 - $ 63.50

Volume

774,481

Average Volume

Market Cap

3.24B

Beta (5Y Monthly)

$ 1.64

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	03-05-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-28-2023	06-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Craig-Hallum Initiates Coverage On Apogee ...
11/03/2025 17:45:02

Craig-Hallum analyst Adam Vogel initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Buy rating and announces Pric...

RBC Capital Maintains Outperform on Apogee...
11/03/2025 14:37:35

RBC Capital analyst Brian Abrahams maintains Apogee Therapeutics (NASDAQ:APGE) with a Outperform and raises the price target...

Mizuho Initiates Coverage On Apogee Therap...
10/21/2025 12:42:28

Mizuho analyst Joseph Catanzaro initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Outperform rating and announc...

BTIG Reiterates Buy on Apogee Therapeutics...
10/09/2025 14:53:14

BTIG analyst Julian Harrison reiterates Apogee Therapeutics (NASDAQ:APGE) with a Buy and maintains $115 price target.

helen-of-troy-ferrari-apogee-therapeutics-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Helen of Troy, Ferrari, Apogee Therapeutic...
10/09/2025 12:29:32

why-richardson-electronics-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket

Why Richardson Electronics Shares Are Trad...
10/09/2025 09:12:11

Reported Earlier, Apogee Therapeutics Pric...
10/09/2025 06:14:57

12 Health Care Stocks Moving In Wednesday'...
10/08/2025 21:06:05

Apogee Therapeutics Launches An Underwritt...
10/08/2025 20:03:48

RBC Capital Initiates Coverage On Apogee T...
09/25/2025 13:40:51

RBC Capital analyst Brian Abrahams initiates coverage on Apogee Therapeutics (NASDAQ: APGE) with a Outperform rating and ann...

Apogee Therapeutics Says Data From Phase 2...
09/11/2025 11:31:55

Apogee Therapeutics, Inc., (NASDAQ:APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with pote...

B of A Securities Maintains Buy on Apogee ...
08/28/2025 15:54:20

B of A Securities analyst Tim Anderson maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target fr...

Apogee Therapeutics Q2 EPS $(1.13) Beats $...
08/11/2025 11:35:45

Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of $...

Gold Falls 1%; ProKidney Shares Spike Higher
07/08/2025 17:25:58

12 Health Care Stocks Moving In Monday's I...
07/07/2025 17:06:57

Dow Dips 1%; Mustang Bio Shares Spike Higher
07/07/2025 16:30:43

top-2-health-care-stocks-that-may-plunge-this-month

Top 2 Health Care Stocks That May Plunge T...
07/07/2025 12:26:53

12 Health Care Stocks Moving In Monday's P...
07/07/2025 12:07:19

CORRECTION: Apogee Therapeutics Ticker Is ...
07/07/2025 11:53:30

apogee-therapeutics-eczema-drug-provides-rapid-itch-relief-in-phase-2-trial

Apogee Therapeutics' Eczema Drug Provides ...
07/07/2025 11:26:21

Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part ...